Tilray Brands (NASDAQ:TLRY - Get Free Report)'s stock had its "sell (d-)" rating reaffirmed by research analysts at Weiss Ratings in a note issued to investors on Wednesday,Weiss Ratings reports.
TLRY has been the subject of a number of other research reports. Zelman & Associates reissued a "neutral" rating on shares of Tilray Brands in a research report on Tuesday, July 29th. Wall Street Zen lowered Tilray Brands to a "strong sell" rating in a research report on Saturday, July 5th. Finally, Jefferies Financial Group boosted their target price on Tilray Brands from $1.50 to $2.00 and gave the stock a "buy" rating in a research report on Monday, August 25th. Two analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $1.94.
View Our Latest Analysis on TLRY
Tilray Brands Stock Up 0.6%
Shares of TLRY traded up $0.01 during trading hours on Wednesday, hitting $1.72. The company had a trading volume of 110,156,286 shares, compared to its average volume of 79,705,928. The firm has a fifty day moving average price of $1.19 and a 200-day moving average price of $0.74. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.49 and a current ratio of 2.46. The stock has a market capitalization of $1.89 billion, a price-to-earnings ratio of -0.74 and a beta of 1.98. Tilray Brands has a 52-week low of $0.35 and a 52-week high of $1.88.
Tilray Brands (NASDAQ:TLRY - Get Free Report) last posted its quarterly earnings results on Monday, July 28th. The company reported $0.02 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.03) by $0.05. Tilray Brands had a negative return on equity of 6.83% and a negative net margin of 265.69%.The firm had revenue of $224.54 million during the quarter, compared to analyst estimates of $250.41 million. On average, equities research analysts forecast that Tilray Brands will post -0.2 EPS for the current fiscal year.
Insider Activity
In related news, CEO Irwin D. Simon acquired 165,000 shares of the business's stock in a transaction that occurred on Wednesday, July 30th. The stock was bought at an average cost of $0.61 per share, for a total transaction of $100,650.00. Following the purchase, the chief executive officer owned 3,941,633 shares in the company, valued at $2,404,396.13. The trade was a 4.37% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 0.84% of the company's stock.
Institutional Inflows and Outflows
A number of hedge funds have recently made changes to their positions in TLRY. Wealth Enhancement Advisory Services LLC grew its stake in shares of Tilray Brands by 317.7% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 166,326 shares of the company's stock valued at $221,000 after acquiring an additional 126,507 shares during the period. California State Teachers Retirement System grew its stake in shares of Tilray Brands by 8.0% during the 4th quarter. California State Teachers Retirement System now owns 778,513 shares of the company's stock valued at $1,035,000 after acquiring an additional 57,544 shares during the period. Garde Capital Inc. bought a new position in shares of Tilray Brands during the 1st quarter valued at approximately $46,000. Madrona Financial Services LLC boosted its stake in Tilray Brands by 42.9% in the 1st quarter. Madrona Financial Services LLC now owns 100,000 shares of the company's stock worth $66,000 after purchasing an additional 30,000 shares during the period. Finally, KBC Group NV boosted its stake in Tilray Brands by 102.6% in the 1st quarter. KBC Group NV now owns 77,657 shares of the company's stock worth $51,000 after purchasing an additional 39,325 shares during the period. 9.35% of the stock is currently owned by institutional investors.
Tilray Brands Company Profile
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tilray Brands, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.
While Tilray Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.